Graduate Program in Zootecnia, Universidade do Estado de Santa Catarina (UDESC), Chapecó, Brazil.
Department of Animal Science, Universidade do Estado de Santa Catarina (UDESC), Chapecó, Brazil.
Microb Pathog. 2020 Dec;149:104570. doi: 10.1016/j.micpath.2020.104570. Epub 2020 Oct 16.
Colibacillosis is a disease caused by Escherichia coli that manifests itself when there are homeostatic imbalances or in the context of increased exposure, in which case the organism displays opportunistic behavior. To control this problem in poultry, antibiotics are used in the feed, because E. coli is component of the intestinal microbiota of birds. However, because of the changing dietary habits of the human population that seeks out healthier foods without antimicrobial residues, there have been many studies of alternatives to replace conventional antimicrobials as performance enhancers. Thus, the objective of the present study was to determine whether daily consumption of a homeopathic product (immune stimulator) by broilers stimulates immune responses and thereby minimizes the negative effects of experimental E. coli infection. We used 320 1-day-old Cobb 500 chicks, distributed in two groups with eight repetitions each, and 20 birds per repetition: control (CG) and homeopathy (HG). HG birds consumed doses of 0.02 mL/bird/day (1-7 d) via water, 0.01 ml/bird (8-21 d), 0.02 ml/bird (22-28 d), 0.01 mL/bird (29-35 d), and 0.02 mL/bird (35-45 d), as recommended by the manufacturer. At day 22 of the birds' life, the two groups were divided into four subgroups, with four repetitions per subgroup. On day 22, birds in CG1 and HG1 groups were infected intraperitoneally with 0.5 mL of inoculum containing 1.0 × 10 CFU of E. coli/mL. During the experimental period, data were collected for analysis of performance. On days 21 and 45 of age, we collected blood and feces. During the first 21 days of the experiment, we found that birds that consumed the immunostimulator had lower neutrophil counts and higher levels of globulins, however without significant difference between groups in terms of performance. Uninfected birds that consumed the homeopathic product in the water had less feed conversion (HG2) between days 1-35 and 1 to 45 compared to the other treatments. Mortality was higher in groups experimentally infected with E. coli (HG1 and CG1) from 22 to 35 days of life. There were greater numbers of lymphocytes in the HG2 group on day 45 than in CG1 and CG2; while numbers of neutrophils were lower at 42 days in birds of groups HG1 and HG2 than in CG1. Lower total bacterial counts, total coliforms and E. coli were observed in the feces of birds in the HG2 group compared to the other groups. Taken together, these findings suggest that inclusion of homeopathic product in the water of broilers had positive effects on the modulation of the immune response and on feed conversion in birds not challenged with E. coli. But the preventive protocol used in this study was not able to minimize the negative effects caused by the experimental E. coli intraperitoneal infection in broilers, featuring a substantial infectious challenge.
大肠杆菌病是由大肠杆菌引起的疾病,当体内出现体内平衡失调或暴露增加时,这种疾病就会显现出来,此时该生物体表现出机会性行为。为了控制家禽中的这个问题,抗生素被添加到饲料中,因为大肠杆菌是鸟类肠道微生物群的一部分。然而,由于人类饮食习惯的改变,人们寻求不含抗菌残留的更健康的食物,因此已经有许多研究替代物来替代常规抗菌药物作为性能增强剂。因此,本研究的目的是确定肉鸡每天食用顺势疗法产品(免疫刺激剂)是否会刺激免疫反应,从而最大限度地减少实验性大肠杆菌感染的负面影响。我们使用了 320 只 1 日龄的科布 500 小鸡,分为两组,每组 8 个重复,每个重复 20 只鸡:对照组(CG)和顺势疗法组(HG)。HG 组鸡通过水摄入 0.02 毫升/只/天(1-7 天)、0.01 毫升/只(8-21 天)、0.02 毫升/只(22-28 天)、0.01 毫升/只(29-35 天)和 0.02 毫升/只(35-45 天),这是制造商推荐的剂量。在鸡的生命的第 22 天,两组被分为四个亚组,每个亚组有四个重复。在第 22 天,CG1 和 HG1 组的鸡通过腹膜内注射含有 1.0×10 CFU/mL 的大肠杆菌的 0.5 毫升接种物进行感染。在实验期间,收集数据进行性能分析。在 21 天和 45 天龄时,我们收集了血液和粪便。在实验的前 21 天,我们发现摄入免疫刺激剂的鸡中性粒细胞计数较低,球蛋白水平较高,但两组在性能方面没有显著差异。与其他处理相比,在第 1 至 35 天和第 1 至 45 天之间,摄入顺势疗法产品的未感染鸡的饲料转化率(HG2)较低。从第 22 天到第 35 天,实验感染大肠杆菌的 HG1 和 CG1 组的死亡率较高。与 CG1 和 CG2 相比,HG2 组在第 45 天的淋巴细胞数量更多;而在第 42 天,HG1 和 HG2 组的鸡中性粒细胞数量较低。与其他组相比,HG2 组鸡的粪便中总细菌计数、总大肠菌群和大肠杆菌数量较低。综上所述,这些发现表明,在不挑战大肠杆菌的情况下,在肉鸡饮水中添加顺势疗法产品对调节免疫反应和饲料转化率有积极影响。但是,本研究中使用的预防方案未能最大限度地减少肉鸡实验性大肠杆菌腹腔感染造成的负面影响,因为这是一个很大的感染挑战。